{
    "startDate": "2020-04-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "AMRX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 266143000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2129000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 582734000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 443956000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 184748000
            },
            {
                "label": "Related party receivables",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1164000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1480874000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 460528000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 527475000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1423826000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 28731000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 4056756000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 599489000
            },
            {
                "label": "Current portion of long-term debt, net",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 29756000
            },
            {
                "label": "Related party payable - short term",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 8455000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 655019000
            },
            {
                "label": "Long-term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 2764578000
            },
            {
                "label": "Note payable - related party",
                "concept": "NotesPayableRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 35661000
            },
            {
                "label": "Related party payable - long term",
                "concept": "DueToAffiliateNoncurrent",
                "unit": "usd",
                "value": 479000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 93772000
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 3018341000
            },
            {
                "label": "Commitments and contingencies (Notes 5 and 17)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 12380000
            },
            {
                "label": "Preferred stock, $0.01 par value, 2,000 shares authorized; none issued at both June 30, 2020 and December 31, 2019",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 617504000
            },
            {
                "label": "Stockholders' accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 274809000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 39696000
            },
            {
                "label": "Total Amneal Pharmaceuticals, Inc. stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 305995000
            },
            {
                "label": "Non-controlling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 65021000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 371016000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 4056756000
            }
        ],
        "cf": [],
        "ic": [
            {
                "label": "Net (loss) income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 23944000
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 11948000
            },
            {
                "label": "Net (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 11996000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 2967000
            },
            {
                "label": "Less: Reclassification of foreign currency translation adjustment included in net loss",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Foreign currency translation adjustments, net",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 2967000
            },
            {
                "label": "Unrealized loss on cash flow hedge, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 9774000
            },
            {
                "label": "Less: Other comprehensive loss (income) attributable to non-controlling interests",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 6471000
            },
            {
                "label": "Other comprehensive (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 6270000
            },
            {
                "label": "Comprehensive (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 18266000
            }
        ]
    }
}